Kissei Pharmaceutical Co Ltd 2022 Annual Report with Sustainability Disclosures
Company: Kissei Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2022
Type: Annual Report with Sustainability Disclosures
Pages: 30
The report highlights Kissei's launches of CAROGRA and TAVNEOS in 2022, expanding treatment options for ulcerative colitis and rare vasculitis. It describes a materiality process covering 15 issues across seven categories, supported by KPIs and TCFD scenario analysis. Environmental disclosures include energy, water, waste, and a target to reduce Scope 1 and 2 CO2 emissions by 46% from fiscal 2013 by fiscal 2030.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.